GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors will be held on Thursday, February 14, 2019 at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase - V, Golf Course Road, Gurugram 122002 to, inter alia, to consider and take on record the Unaudited Financial Results for the Third Quarter ended December 31, 2018 with Limited Review by Auditors. We request you to take the above information on record.

Pdf Link: Glaxosmithkline Consumer Healthcare Ltd. - Board Meeting Intimation for Notice Of Board Meeting To Consider And Take On Record The Unaudited Financial Results.

Source : BSE - www.bseindia.com